Matarin Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$1.32M Buy
48,372
+36,884
+321% +$1M 0.32% 130
2020
Q3
$212K Buy
+11,488
New +$212K 0.04% 193
2018
Q2
Sell
-22,632
Closed -$506K 326
2018
Q1
$506K Sell
22,632
-2,723
-11% -$60.9K 0.04% 246
2017
Q4
$534K Hold
25,355
0.04% 244
2017
Q3
$631K Hold
25,355
0.05% 227
2017
Q2
$492K Buy
25,355
+2,333
+10% +$45.2K 0.05% 223
2017
Q1
$425K Buy
+23,022
New +$425K 0.04% 230